ELAB vs LH · rev $2.0M vs P/E 23, rev $13.95B
Elevai Labs, Inc. Common Stock (ELAB) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported LH revenue for 2025-12-31 was $13.95B. Net income was $876.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
ELAB currently screens at market cap $6.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the ELAB and LH stock pages for the full models.
Not investment advice.